Xenon Pharmaceuticals

Filed a patent for "crystalline forms" on Thu, July 27, 2023

Filed a patent for "conjoint therapy for treating seizure disorders" on Thu, December 12, 2024

Filed a patent for "pyridinylacetamide derivatives as sodium channel activators" on Thu, June 29, 2023

Filed a patent for "pyridine derivatives and their use as sodium channel activators" on Thu, May 11, 2023

Filed a patent for "pyridinyl derivatives as sodium channel activators" on Thu, May 18, 2023

Filed a patent for "use of the nav1.6 sodium channel blocker (s)-4-((1-benzylpyrrolidin-3-yl)(methyl)amino)-2-fluoro-5-methyl-n(thiazol-4-yl)benzenesulfonamide, together with strong inducers of cytochrome p450 3a4, in the treatment of conditions associated with navi.6 activity" on Thu, December 21, 2023

Filed a patent for "pharmaceutical formulations for treating diseases associated with voltage-gated sodium channels" on Thu, December 21, 2023

Filed a patent for "pyridinamine derivatives and their use as potassium channel modulators" on Thu, March 28, 2024